Correction: An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease.

Reading, C. L., Yan, J., Testa, M. A., Simonson, D. C., Javaid, H., Schmunk, L., Martin-Herranz, D. E., Brooke, R., Gordevicius, J., Zhang, J., Yuan, H., Ahlem, C., Wang, L., Markham, P., Osman, N., O’Quinn, S., & Palumbo, J. (2025). Correction: An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer’s disease.. Frontiers in Neuroscience, 19, 1758523.